Potent inhibition of SARS-associated coronavirus (SCoV) infection and replication by type I interferons (IFN-α/β) but not by type II interferon (IFN-γ)

Journal of Interferon and Cytokine Research

Volumn 24, Issue 7, 2004, Pages 388-390

  Zheng, Bojian ^a   He, Ming Liang ^b   Wong, King Ling ^a   Ching, Tung Lum ^b   Poon, Leo L M ^a   Peng, Ying ^b   Guan, Yi ^a   Lin, Marie C M ^b   Kung, Hsiang Fu ^a,b  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; GAMMA INTERFERON; GENOMIC RNA; RECOMBINANT ALPHA2A INTERFERON; RECOMBINANT BETA INTERFERON; RECOMBINANT GAMMA INTERFERON;

ANIMAL CELL; ANTIVIRAL ACTIVITY; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOPATHOGENIC EFFECT; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SARS CORONAVIRUS; SEVERE ACUTE RESPIRATORY SYNDROME; VIRUS CELL INTERACTION; VIRUS INHIBITION; VIRUS REPLICATION;

ANTIVIRAL AGENTS; CELL LINE; CYTOPATHOGENIC EFFECT, VIRAL; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; INTERFERON TYPE I; INTERFERON TYPE II; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, VIRAL; SARS VIRUS; SIGNAL TRANSDUCTION; VIRUS REPLICATION;

ANIMALIA; CORONAVIRUS; RNA VIRUSES; SARS CORONAVIRUS;

EID: 3242885894     PISSN: 10799907     EISSN: None     Source Type: Journal    
DOI: 10.1089/1079990041535610     Document Type: Article

References (9)

1. KSIAZEK, T.G., ERDMAN, D., GOLDSMITH, C.S., ZAKI, S.R., PERET, T., EMERY, S., TONG, S., URBANI, C., COMER, J.A., LIM, W., ROLLIN, P.E., DOWELL, S.F., LING, A.E., HUMPHREY, C.D., SHIEH, W.J., GUARNER, J., PADDOCK, C.D., ROTA, P., FIELDS, B., DERISI, J., YANG, J.Y., COX, N., HUGHES, J.M., LEDUC, J.W., BELLINI, W.J., ANDERSON, L.J., and SARS WORKING GROUP (2003). A novel coronavirus associated with severe acute respiratory syndrome. N. Engl. J. Med. 348, 1953-1966.
2. PEIRIS, J.S., LAI, S.T., POON, L.L., GUAN, Y., YAM, L.Y., LIM, W., NICHOLLS, J., YEE, W.K., YAN, W.W., CHEUNG, M.T., CHENG, V.C., CHAN, K.H., TSANG, D.N., YUNG, R.W., NG, T.K., YUEN, K.Y., and SARS STUDY GROUP (2003). Coronavirus as a possible cause of severe acute respiratory syndrome. Lancet 361, 1319-1325.
3. PESTKA, S. (2000). The human interferon alpha species and receptors. Biopolymers 55, 254-287.
4. FALTYNEK, C.R., and KUNG, H.F. (1988). The biochemical mechanisms of action of the interferons. Biofactors 1, 227-235.
5. PESTKA, S., KOTENKO, S.V., MUTHUKUMARAN, G., IZOTOVA, L.S., COOK, J.R., and GAROTTA, G. (1997) The interferon gamma (IFN-gamma) receptor: a paradigm for the multichain cytokine receptor. Cytokine Growth Factor Rev. 8, 189-206.
6. POON, L.L., WONG, O.K., LUK, W., YUEN, K.Y., PEIRIS, J.S., and GUAN, Y. (2003). Rapid diagnosis of a coronavirus associated with severe acute respiratory syndrome (SARS). Clin. Chem. 49, 953-955.
7. CINATL, J., MORGENSTERN, B., BAUER, G., CHANDRA, P., RABENAU, H., and DOERR, H.W. (2003). Treatment of SARS with human interferons. Lancet 362, 293-294.
8. ANTONELLI, G., SCAGNOLARI, C., VICENZI, E., and CLEMENTI, M. (2003). Treatment of SARS with human interferons. Lancet 362, 1158-1159.
9. HAAGMANS, B.L., KUIKEN, T., MARTINA, B.E., FOUCHIER, R.A., RIMMELZWAAN, G.F., VAN AMERONGEN, G., VAN RIEL, D., DE JONG, T., ITAMURA, S., CHAN, K.H., TASHIRO, M., and OSTERHAUS, A.D. (2004). Pegylated interferon-alpha protects type 1 pneumocytes against SARS coronavirus infection in macaques. Nat. Med. 10, 290-293.